Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use
Isabelle C. Van Gelder, Jonathan Piccini, M Glikson, Dragoş Vinereanu et al.
Citations
2 citations
Journal
JAMA Cardiology
Topics
Atrial Fibrillation Management and Outcomes
Field-Weighted Citation Impact (FWCI)
2.78
article
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use
Isabelle C. Van Gelder, Jonathan Piccini, M Glikson, Dragoş Vinereanu, Erik Lerkevang Grove, Manesh R. Patel, Juan José Gómez‐Doblas, Rosa Coppolecchia, Jan Steffel, Valeria Caso, Hardi Mundl, Béla Benczúr, Assen Goudev, Shaun G. Goodman, Sigrun Halvorsen, Elizabeth Lydon, Renato D. Lópes, John Hunter Alexander, Thomas Viethen, Roopinder K. Sandhu, Keith C. Ferdinand, Tuomas Kiviniemi, Jonas Oldgren, Frank W. Rockhold, Andrea M. Russo, Anne-Céline Martin
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
JAMA CardiologyVol. 10(6)
Institutions
Tulane University (US), Uppsala University (SE), Oslo University Hospital (NO), St. Michael's Hospital (CA), University Health Network (CA), University Medical Center Groningen (NL), Bayer (United States) (US), University of Alberta (CA), University of Turku (FI), Carol Davila University of Medicine and Pharmacy (RO), University of Calgary (CA), University of Groningen (NL), Duke University (US), University of Toronto (CA), Université Paris Cité (FR), University of Perugia (IT), Instituto de Salud Carlos III (ES), Shaare Zedek Medical Center (IL), Turku University Hospital (FI), Aarhus University Hospital (DK), Medical University of Sofia (BG), Clinical Research Institute (US), Cooper Medical School of Rowan University (US), Assistance Publique – Hôpitaux de Paris (FR), Klinik Hirslanden (CH), Hôpital Européen Georges-Pompidou (FR), Canadian VIGOUR Centre (CA), Centro de Investigación Biomédica en Red (ES), Szent János Kórház (HU), Duke Medical Center (US), Instituto de Investigación Biomédica de Málaga (ES), Libin Cardiovascular Institute of Alberta (CA), Bayer (Germany) (DE), Universidad de Málaga (ES)